News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
La Jolla Pharmaceutical Company Plans Liquidation
August 4, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Xconomy.com -- San Diego’s La Jolla Pharmaceuticals plans to ask shareholders to approve a liquidation plan at a not-yet-scheduled special shareholders meeting, according to a recent SEC filing.
Twitter
LinkedIn
Facebook
Email
Print
Bankruptcy
MORE ON THIS TOPIC
Deals
Novartis tightens bond with Orionis in up to $1.4B molecular glue deal
June 11, 2026
·
2 min read
·
Tristan Manalac
IPO
Update: Parabilis raises industry-record $670M IPO
June 10, 2026
·
2 min read
·
Gabrielle Masson
Alzheimer’s disease
Lilly bets up to $1B+ with AlzeCure in search for next Alzheimer’s act
June 10, 2026
·
2 min read
·
Tristan Manalac
Podcast
Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence
June 10, 2026
·
2 min read
·
Jef Akst